Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles

about

Surface modification-mediated biodistribution of ¹³C-fullerene C₆₀ in vivo Hydroxysafﬂor yellow A exerts antioxidant effects in a rat model of traumatic brain injury.

P2860

Q36668016-00447D4E-A2E9-4D06-9294-4AEF99A186B0 Q37297462-8DAF8268-4044-46FF-9B4D-F8DB8AEE6212

P2860

Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles

Item

http://www.wikidata.org/entity/Q41854707

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Mechanism of enhanced oral abs ...... d in hydrophobic nanoparticles

@en

type

Item

label

Mechanism of enhanced oral abs ...... d in hydrophobic nanoparticles

@en

prefLabel

Mechanism of enhanced oral abs ...... d in hydrophobic nanoparticles

@en

P1476

Mechanism of enhanced oral abs ...... d in hydrophobic nanoparticles

@en

P2093

Chen-Qi Tong

http://www.w3.org/2001/XMLSchema#string

Jia Yu

http://www.w3.org/2001/XMLSchema#string

Jian-Qing Gao

http://www.w3.org/2001/XMLSchema#string

Liang-Zhong Lv

http://www.w3.org/2001/XMLSchema#string

Min Han

http://www.w3.org/2001/XMLSchema#string

P2860

Ethanol modulation of intestinal epithelial tight junction barrier

Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies

Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A

Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation

Guanxin II (II) for the management of coronary heart disease.

Hydroxysafflor yellow a inhibits lipopolysaccharide-induced inflammatory signal transduction in human alveolar epithelial A549 cells.

Folic acid functionalized nanoparticles for enhanced oral drug delivery.

Upregulation of heme oxygenase-1 expression by hydroxysafflor yellow A conferring protection from anoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes.

Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.

Pharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome rats.

P304

2709-2717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S47400

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255736647

http://www.w3.org/2001/XMLSchema#string

P698

23935363

http://www.w3.org/2001/XMLSchema#string

P932

3735274

http://www.w3.org/2001/XMLSchema#string

Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles

about

P2860

P2860

Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932